Recent developments in uterine mesenchymal neoplasms (Q38067441)

28 August 2017

1 reference

title

Recent developments in uterine mesenchymal neoplasms (English)

1 reference

28 August 2017

2

Esther Oliva

1 reference

28 August 2017

Sarah Chiang

1

1 reference

28 August 2017

1 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

62

1 reference

28 August 2017

1

1 reference

28 August 2017

124-137

1 reference

MED12 alterations in both human benign and malignant uterine soft tissue tumors

28 August 2017

1 reference

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients

21 January 2018

1 reference

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy

21 January 2018

1 reference

The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital

21 January 2018

1 reference

The management of patients with uterine sarcoma: a debated clinical challenge

21 January 2018

1 reference

Smooth muscle, endometrial stromal, and mixed Müllerian tumors of the uterus

21 January 2018

1 reference

The pathology of uterine smooth muscle tumors and mixed endometrial stromal-smooth muscle tumors: a selective review with emphasis on recent advances

21 January 2018

1 reference

Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity.

21 January 2018

1 reference

Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study.

21 January 2018

1 reference

Mesenchymal tumors of the uterus VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear-cell leiomyoma.A clinical and pathologic analysis of 26 cases

21 January 2018

1 reference

A case of benign metastasizing leiomyoma treated by surgical castration followed by an aromatase inhibitor, anastrozole

21 January 2018

1 reference

Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma

21 January 2018

1 reference

Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems

21 January 2018

1 reference

Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: a study of 86 cases

21 January 2018

1 reference

A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma

21 January 2018

1 reference

Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours

21 January 2018

1 reference

Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas.

21 January 2018

1 reference

Uterine leiomyosarcoma arising in leiomyoma: clinicopathological study of four cases and literature review.

21 January 2018

1 reference

Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma

21 January 2018

1 reference

MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors

21 January 2018

1 reference

A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors

21 January 2018

1 reference

The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors

21 January 2018

1 reference

Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis.

21 January 2018

1 reference

Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.

21 January 2018

1 reference

The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study

21 January 2018

1 reference

Fascin expression in uterine smooth muscle tumors.

21 January 2018

1 reference

Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors

21 January 2018

1 reference

Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT

21 January 2018

1 reference

MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas

21 January 2018

1 reference

The human Mediator complex: a versatile, genome-wide regulator of transcription

21 January 2018

1 reference

Mediator is a transducer of Wnt/beta-catenin signaling.

21 January 2018

1 reference

Mediator modulates Gli3-dependent Sonic hedgehog signaling

21 January 2018

1 reference

MED12 exon 2 mutations are common in uterine leiomyomas from South African patients.

21 January 2018

1 reference

Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.

21 January 2018

1 reference

Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas

21 January 2018

1 reference

A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma

21 January 2018

1 reference

Dual targeting of mTOR and aurora-A kinase for the treatment of uterine Leiomyosarcoma

21 January 2018

1 reference

PDGFR-alpha as a potential therapeutic target in uterine sarcomas

21 January 2018

1 reference

The Akt-mTOR tango and its relevance to cancer

21 January 2018

1 reference

A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy

21 January 2018

1 reference

Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma

21 January 2018

1 reference

Uterine endometrial stromal sarcoma with rhabdoid and smooth muscle differentiation

21 January 2018

1 reference

Low-grade endometrial stromal sarcoma with intracardiac extension. Evolution of extensive smooth muscle differentiation and usefulness of immunohistochemistry for its recognition and distinction from intravenous leiomyomatosis

21 January 2018

1 reference

High-grade endometrial stromal sarcoma with smooth muscle and skeletal muscle differentiation: report of a case with cytomorphologic and immunocytologic analysis.

21 January 2018

1 reference

Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases.

21 January 2018

1 reference

Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation

21 January 2018

1 reference

Uterine endometrial stromal sarcoma with smooth muscle and glandular differentiation

21 January 2018

1 reference

Endometrial low-grade stromal sarcoma with ovarian sex cord-like differentiation: report of two cases with an immunohistochemical and flow cytometric study.

21 January 2018

1 reference

Endometrial stromal sarcoma with sex cord-like areas and focal rhabdoid differentiation.

21 January 2018

1 reference

Endometrial stromal sarcoma of the uterus with rhabdoid features

21 January 2018

1 reference

Myxoid endometrial stromal sarcoma of the uterus

21 January 2018

1 reference

Symplastic atypia in neoplastic and non-neoplastic endometrial stroma: report of 3 cases with a review of atypical symplastic cells within the female genital tract

21 January 2018

1 reference

Endometrial stromal sarcomas: a review of potential prognostic factors

21 January 2018

1 reference

Hysteroscopic endomyometrial resection of three uterine sarcomas

21 January 2018

1 reference

The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma

21 January 2018

1 reference

Mixed low grade and high grade endometrial stromal sarcoma of uterus: differences on immunohistochemistry and chromosome in situ hybridisation.

21 January 2018

1 reference

Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases

21 January 2018

1 reference

Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.

21 January 2018

1 reference

Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases

21 January 2018

1 reference

CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms

21 January 2018

1 reference

Uterine tumors resembling ovarian sex cord tumors are polyphenotypic neoplasms with true sex cord differentiation

21 January 2018

1 reference

Endometrial stromal neoplasms are immunoreactive with WT-1 antibody

21 January 2018

1 reference

Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma

21 January 2018

1 reference

Low-grade endometrial stromal sarcoma: hormonal aspects

21 January 2018

1 reference

Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors

21 January 2018

1 reference

Diagnostic use of nuclear beta-catenin expression for the assessment of endometrial stromal tumors.

21 January 2018

1 reference

Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas.

21 January 2018

1 reference

Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy.

21 January 2018

1 reference

Expression of androgen receptors in benign and malignant endometrial stromal neoplasms

21 January 2018

1 reference

Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement

21 January 2018

1 reference

Cytogenetic and molecular aberrations in endometrial stromal tumors

21 January 2018

1 reference

The cytogenetics and molecular biology of endometrial stromal sarcoma

21 January 2018

1 reference

Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors

21 January 2018

1 reference

JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue

21 January 2018

1 reference

Molecular Detection of JAZF1-JJAZ1 Gene Fusion in Endometrial Stromal Neoplasms with Classic and Variant Histology

21 January 2018

1 reference

Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms

21 January 2018

1 reference

High frequency of JAZF1-JJAZ1 gene fusion in endometrial stromal tumors with smooth muscle differentiation by interphase FISH detection.

21 January 2018

1 reference

A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells

21 January 2018

1 reference

Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma

21 January 2018

1 reference

Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma

21 January 2018

1 reference

14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma

21 January 2018

1 reference

Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation

21 January 2018

1 reference

Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12048

1 reference

28 August 2017

1 reference

PubMed ID

23240674